TrialAllergy2018

Short course of grass allergen peptides immunotherapy over 3 weeks reduces seasonal symptoms in allergic rhinoconjunctivitis with/without asthma: A randomized, multicenter, double-blind, placebo-controlled trial.

R Mösges et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.